|
Volumn 36, Issue 3, 2007, Pages 664-665
|
Commentary: Measuring the success of blinding in RCTs: Don't, must, can't or needn't?
|
Author keywords
Bias; Blinding; Co intervention; Contamination; Randomised trials
|
Indexed keywords
ACETYLSALICYLIC ACID;
PLACEBO;
SULFINPYRAZONE;
URIC ACID;
ANALYTICAL ERROR;
CAREGIVER;
CAROTID ENDARTERECTOMY;
CLINICAL TRIAL;
COCHRANE LIBRARY;
CONTROLLED CLINICAL TRIAL;
DRUG EFFICACY;
HUMAN;
HYPERTENSION;
MEDICAL RESEARCH;
NOTE;
PREDICTION;
PRIORITY JOURNAL;
PUBLICATION;
RANDOMIZED CONTROLLED TRIAL;
STROKE;
SYMPTOM;
THROMBOCYTE;
TRANSIENT ISCHEMIC ATTACK;
URIC ACID BLOOD LEVEL;
BIAS (EPIDEMIOLOGY);
DOUBLE-BLIND METHOD;
HUMANS;
RANDOMIZED CONTROLLED TRIALS;
RESEARCH DESIGN;
|
EID: 34547830376
PISSN: 03005771
EISSN: 14643685
Source Type: Journal
DOI: 10.1093/ije/dym088 Document Type: Note |
Times cited : (118)
|
References (6)
|